Calyxo
PrivateLast Round
Series F
Apr 14, 2026
Est. Valuation
$400M
Total Funding Raised
$165.22M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Calyxo operates in Healthcare & Life Sciences and is based in Pleasanton, California. Its latest recorded funding round was a Series F round in April 2026.
Calyxo is a medical device company that develops minimally invasive technology for kidney stone removal, including the CVAC Aspiration System.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Calyxo Comparables
Compare Calyxo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cortex, Inc. | 80% | |
| Well Lead Med Co Ltd | 77% | |
| Olympus | 75% |
For institutional investors. Book with your work email.
Calyxo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Apr 14, 2026 | ||||
| Series E | Dec 26, 2024 | ||||
| Series D | Dec 12, 2023 | ||||
| Series C | Jul 6, 2022 | ||||
| Series B | Oct 15, 2019 | ||||
Series A | Aug 16, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Calyxo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series F |
| Ally Bridge Group | Series F |
| Questa Capital | Series D, Series B, Series E, Series F, Series C |
| Avidity Partners Management | Series D |
| Avidity Partners | Series D |
| CRG | Series D, Series E, Series F, Series C |
| VIC Technology Venture Development | Series A, Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 34% MoM, reaching 5K.
- Aug 20, 2026
Monthly visitors increased 132% MoM, reaching 3.7K.
For institutional investors. Book with your work email.
Calyxo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Calyxo's valuation, stock price, and market status.
Is Calyxo a public or private company?
Calyxo is a private company.
What is the current stock price of Calyxo?
Calyxo is a private company, so its shares have no public market price. Caplight tracks Calyxo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Calyxo worth (valuation)?
Calyxo's valuation is estimated at $400.0M based on funding round data.
Can I buy Calyxo stock?
Calyxo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Calyxo's last funding round?
Calyxo's most recent funding round was Series F on April 14, 2026.
Who are the main investors in Calyxo?
Key investors in Calyxo include Janus Henderson Group, Ally Bridge Group, Questa Capital, Avidity Partners Management, Avidity Partners.
Will Calyxo IPO soon?
No public IPO plans have been announced for Calyxo.
How can I track Calyxo secondary market activity?
Caplight tracks bids, offers, and trades in Calyxo's shares on secondary markets.